Follow
giovanni pellegrini
giovanni pellegrini
Verified email at uzh.ch
Title
Cited by
Cited by
Year
Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
C Müller, CA Umbricht, N Gracheva, VJ Tschan, G Pellegrini, P Bernhardt, ...
European journal of nuclear medicine and molecular imaging 46, 1919-1930, 2019
1552019
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies
JA Heslop, TG Hammond, I Santeramo, A Tort Piella, I Hopp, J Zhou, ...
Stem cells translational medicine 4 (4), 389-400, 2015
1342015
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus
CE Faliti, R Gualtierotti, E Rottoli, M Gerosa, L Perruzza, A Romagnani, ...
Journal of Experimental Medicine 216 (2), 317-336, 2019
1002019
A micron-scale surface topography design reducing cell adhesion to implanted materials
F Robotti, S Bottan, F Fraschetti, A Mallone, G Pellegrini, N Lindenblatt, ...
Scientific reports 8 (1), 10887, 2018
952018
T follicular helper cells promote a beneficial gut ecosystem for host metabolic homeostasis by sensing microbiota-derived extracellular ATP
L Perruzza, G Gargari, M Proietti, B Fosso, AM D’Erchia, CE Faliti, ...
Cell reports 18 (11), 2566-2575, 2017
932017
ATP released by intestinal bacteria limits the generation of protective IgA against enteropathogens
M Proietti, L Perruzza, D Scribano, G Pellegrini, R D’Antuono, F Strati, ...
Nature communications 10 (1), 250, 2019
702019
Enhanced therapeutic activity of non-internalizing small-molecule-drug conjugates targeting carbonic anhydrase IX in combination with targeted interleukin-2
S Cazzamalli, B Ziffels, F Widmayer, P Murer, G Pellegrini, F Pretto, ...
Clinical Cancer Research 24 (15), 3656-3667, 2018
692018
Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate
S Haller, G Pellegrini, C Vermeulen, NP van der Meulen, U Köster, ...
EJNMMI research 6, 1-11, 2016
652016
Microengineered biosynthesized cellulose as anti-fibrotic in vivo protection for cardiac implantable electronic devices
F Robotti, I Sterner, S Bottan, JMM Rodríguez, G Pellegrini, T Schmidt, ...
Biomaterials 229, 119583, 2020
532020
The antibody‐based delivery of interleukin‐12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune checkpoint inhibitors
E Puca, P Probst, M Stringhini, P Murer, G Pellegrini, S Cazzamalli, ...
International journal of cancer 146 (9), 2518-2530, 2020
462020
Potency-matched dual cytokine–antibody fusion proteins for cancer therapy
R De Luca, A Soltermann, F Pretto, C Pemberton-Ross, G Pellegrini, ...
Molecular cancer therapeutics 16 (11), 2442-2451, 2017
422017
Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models
D Meier, SM Botter, C Campanile, B Robl, S Gräfe, G Pellegrini, W Born, ...
International journal of cancer 140 (7), 1680-1692, 2017
422017
The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction
T Knöpfel, EM Pastor-Arroyo, U Schnitzbauer, DV Kratschmar, A Odermatt, ...
Scientific reports 7 (1), 11018, 2017
372017
PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD
S Grimaudo, S Bartesaghi, R Rametta, F Marra, R Margherita Mancina, ...
Liver International 41 (2), 321-332, 2021
282021
Universal toxin-based selection for precise genome engineering in human cells
S Li, N Akrap, S Cerboni, MJ Porritt, S Wimberger, A Lundin, C Möller, ...
Nature communications 12 (1), 497, 2021
282021
PSD3 downregulation confers protection against fatty liver disease
RM Mancina, K Sasidharan, A Lindblom, Y Wei, E Ciociola, ...
Nature metabolism 4 (1), 60-75, 2022
232022
Human CD34+ Hematopoietic Stem Cell–Engrafted NSG Mice: Morphological and Immunophenotypic Features
S Blümich, H Zdimerova, C Münz, A Kipar, G Pellegrini
Veterinary pathology 58 (1), 161-180, 2021
232021
Bovine fetal placenta during pregnancy and the postpartum period
C Botta, G Pellegrini, M Hässig, T Pesch, B Prähauser, S Wunderlin, ...
Veterinary pathology 56 (2), 248-258, 2019
222019
Recent advancements and applications of human immune system mice in preclinical immuno-oncology
M Curran, M Mairesse, A Matas-Céspedes, B Bareham, G Pellegrini, ...
Toxicologic Pathology 48 (2), 302-316, 2020
212020
Hyperoxia-induced lung structure–function relation, vessel rarefaction, and cardiac hypertrophy in an infant rat model
F Greco, S Wiegert, P Baumann, S Wellmann, G Pellegrini, V Cannizzaro
Journal of translational medicine 17, 1-11, 2019
212019
The system can't perform the operation now. Try again later.
Articles 1–20